Evidence map›Paper›PMID 26106289›Full record

ReviewFrontiers in neuroscience2015

Reporter cell lines to evaluate the selectivity of chemicals for human and zebrafish estrogen and peroxysome proliferator activated γ receptors.

Marina Grimaldi, Abdelhay Boulahtouf, Vanessa Delfosse, Erwan Thouennon, William Bourguet, Patrick Balaguer

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. The Preservation ofGenes · 2022
    Article
  3. Evaluation of a multiplexed, multispecies nuclear receptor assay for chemical hazard assessment.Toxicology in vitro : an international journal published in association with BIBRA · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Marina GrimaldiInstitut de Recherche en Cancérologie de Montpellier Montpellier, France ; Institut National de la Santé et de la Recherche Médicale U1194 Montpellier, France ; Université Montpellier Montpellier, France ; Institut Reìgional du Cancer de Montpellier Montpellier, France.
Abdelhay BoulahtoufInstitut de Recherche en Cancérologie de Montpellier Montpellier, France ; Institut National de la Santé et de la Recherche Médicale U1194 Montpellier, France ; Université Montpellier Montpellier, France ; Institut Reìgional du Cancer de Montpellier Montpellier, France.
Vanessa DelfosseInstitut National de la Santé et de la Recherche Médicale U1054 Montpellier, France ; Centre National de la Recherche Scientifique UMR5048, Centre de Biochimie Structurale, Université Montpellier Montpellier, France.
Erwan ThouennonInstitut de Recherche en Cancérologie de Montpellier Montpellier, France ; Institut National de la Santé et de la Recherche Médicale U1194 Montpellier, France ; Université Montpellier Montpellier, France ; Institut Reìgional du Cancer de Montpellier Montpellier, France.
William BourguetInstitut National de la Santé et de la Recherche Médicale U1054 Montpellier, France ; Centre National de la Recherche Scientifique UMR5048, Centre de Biochimie Structurale, Université Montpellier Montpellier, France.
Patrick BalaguerInstitut de Recherche en Cancérologie de Montpellier Montpellier, France ; Institut National de la Santé et de la Recherche Médicale U1194 Montpellier, France ; Université Montpellier Montpellier, France ; Institut Reìgional du Cancer de Montpellier Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier · FRUniversité de Montpellier · FRInserm · FRInstitut Regional du Cancer de Montpellier

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zebrafish is increasingly used as an animal model to study the effects of environmental nuclear receptors (NRs) ligands. As most of these compounds have only been tested on human NRs, it is necessary to measure their effects on zebrafish NRs. Estrogen receptors (ER) α and β and peroxysome proliferator activated receptor (PPAR) γ are main targets of environmental disrupting compounds (EDCs). In humans there are two distinct nuclear ERs (hERα and hERβ), whereas the zebrafish genome encodes three ERs, zfERα, zfERβ1, and zfERβ2. Only one isoform of PPARγ is expressed in both humans and zebrafish. In this review, we described reporter cell lines that we established to study the interaction of EDCs with human and zebrafish ERs and PPARγ. Using these cell lines, we observed that zfERs are thermo-sensitive while zfPPARγ is not. We also showed significant differences in the ability of environmental and synthetic ligands to modulate activation of zfERs and zfPPARγ in comparison to hERs and hPPARγ. Some environmental estrogens (bisphenol A, mycoestrogens) which are hER panagonists displayed greater potency for zfERα as compared to zfERβs. hERβ selective agonists (8βVE2, DPN, phytoestrogens) also displayed zfERα selectivity. Among hERα selective synthetic agonists, 16α-LE2 was the most zfERα selective compound. Almost all zfPPARγ environmental ligands (halogenated bisphenol A derivatives, phthalates, perfluorinated compounds) displayed similar affinity for human and zebrafish PPARγ while pharmaceutical hPPARγ agonists like thiazolidones are not recognized by zfPPARγ. Altogether, our studies show that all hERs and hPPARγ ligands do not control in a similar manner the transcriptional activity of zfERs and zfPPARγ and point out that care has to be taken in transposing the results obtained using the zebrafish as a model for human physiopathology.

Indexed as

environmental disrupting compoundsestrogen receptorhumanperoxysome proliferator activated receptor γreporter cell lineszebrafish

Identifiers

PMID26106289
PMCPMC4460427
OpenAlexW1599864479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.